Jay A. Fishman Ltd’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.8M | Buy |
556,150
+23,000
| +4% | +$322K | 0.75% | 25 |
|
|
2025
Q1 | $8.34M | Sell |
533,150
-3,250
| -0.6% | -$50.8K | 0.91% | 20 |
|
|
2024
Q4 | $7.47M | Buy |
536,400
+118,400
| +28% | +$1.65M | 0.7% | 22 |
|
|
2024
Q3 | $3.89M | Buy |
418,000
+71,400
| +21% | +$664K | 0.39% | 31 |
|
|
2024
Q2 | $3.22M | Buy |
346,600
+122,300
| +55% | +$1.14M | 0.34% | 31 |
|
|
2024
Q1 | $2.22M | Buy |
224,300
+171,300
| +323% | +$1.7M | 0.25% | 35 |
|
|
2023
Q4 | $171K | Sell |
53,000
-34,000
| -39% | -$110K | 0.02% | 89 |
|
|
2023
Q3 | $462K | Buy |
87,000
+10,000
| +13% | +$53.1K | 0.06% | 66 |
|
|
2023
Q2 | $734K | Buy |
77,000
+13,200
| +21% | +$126K | 0.09% | 56 |
|
|
2023
Q1 | $702K | Buy |
63,800
+20,000
| +46% | +$220K | 0.09% | 55 |
|
|
2022
Q4 | $648K | Sell |
43,800
-3,000
| -6% | -$44.4K | 0.09% | 58 |
|
|
2022
Q3 | $894K | Buy |
46,800
+25,800
| +123% | +$493K | 0.13% | 50 |
|
|
2022
Q2 | $448K | Buy |
+21,000
| New | +$448K | 0.06% | 68 |
|